J&J Talc Suit Dismissals: Plaintiffs Lack Causation Thread For Proof Quilt
This article was originally published in The Rose Sheet
Executive Summary
Following two plaintiff victories and hefty damages awards in a Missouri circuit court earlier this year, J&J succeeded last week in having a pair of talc cancer cases dismissed in New Jersey due to plaintiffs’ lack of compelling causation evidence. With more than 1,000 talc suits against J&J still pending, the relative weight of expert testimonies – and venue – likely will continue to be significant factors in how they play out.
You may also be interested in...
Court’s Rejection Of Evidence Countering ‘Willful’ Deception On Talc Ends J&J’s Appeal Streak
Johnson & Johnson failed to convince a Missouri appeals court to overturn a lower court finding that plaintiffs presented clear and convincing evidence the talc in its Johnson’s Baby Powder causes ovarian cancer and that the firm knew and improperly influenced regulators to allow use of the ingredient.
J&J’s Discontinuation Of Johnson’s Baby Powder Linked To April Federal Court Ruling
Legal experts note that J&J’s decision to end Johnson’s Baby Powder sales in the US and Canada closely followed a New Jersey federal court decision that largely denied the firm’s motions to bar testimony from plaintiff experts in multi-district talc litigation comprising around 16,000 cases.
Canadian Authorities Say Some Cosmetic Talc Applications May Endanger Human Health
Health Canada and Canada’s environmental agency issued a draft screening assessment Dec. 8 identifying talc as potentially hazardous to consumers when used in cosmetic powders that may be inhaled or products applied to female genitals. Finalization of the assessment in its current form would trigger risk management actions.